<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        128-124-20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MIXIF
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CEFIXIME
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        60
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        25.15
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DAR ALDAWA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01DD08 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Mixif</strong><sup>&Ograve;</sup> belongs to a group of medicines called cephalosporins, which are antibiotics used for treating infections caused by bacteria.</p><p><strong>Mixif</strong><sup>&Ograve;</sup> can be used to treat:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; infection of the middle ear</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sinus infection</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; throat infection</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; infection causing sudden worsening of long-standing bronchitis</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; serious lung infections (such as pneumonia) acquired outside the hospital</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; infections in the urinary tract</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; kidney infection</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not give Mixif</strong><sup>&Ograve;</sup><strong> to your child if: </strong></p><p>- they are allergic to cefixime or any of the other ingredients of this medicine (listed in section 6).</p><p>- they are allergic to any other cephalsporin type of antibiotic.</p><p>- they have ever had a severe allergic reaction to penicillin or to any other beta-lactam type of antibiotic.</p><p>- your child has been born prematurely or is a newborn infant under 1 month old</p><p><strong>Warnings and precautions </strong></p><p>Talk to your doctor or pharmacist before giving this medicine to your child if:</p><p>- your child is mild to moderately allergic to penicillin antibiotics or to any other beta-lactam type of antibiotics. Not all people who are allergic to penicillin are also allergic to cephalsporins. However, you should take special care, as your child might also be allergic to this medicine.</p><p>- they have any kidney problems the use of <strong>Mixif</strong><sup>&Ograve;</sup> is not recommended. If you are an adult who has kidney problems your doctor may recommend a lower dose for you.</p><p>- they have previously taken cephalosporin antibiotics and experienced a reduction in their red blood cells that made their skin yellow and caused weakness or breathlessness (haemolytic anaemia)</p><p><u>During treatment </u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your child has severe or persistent diarrhoea, which may be bloody with stomach pain or cramps, during or shortly after treatment with <strong>Mixif</strong><sup>&Ograve;</sup>, stop giving this medicine and contact your doctor immediately. Medicines which may slow or stop bowel movements must not be given.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Talk to your doctor or pharmacist if your child feels breathless, with yellowing of the skin and eyes, this may be due to the breakdown of red blood cells.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your child develops fever, with lower back pain and problems passing water, you should stop giving them the medicine and take them to the doctor.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your child develops a fever, sore throat, rash with blisters or ulcers in the mouth or on the face, body, arms or legs, you should stop giving them the medicine and see the doctor straight away.</p><p><u>Effect on laboratory tests </u></p><p>If your child needs any blood or urine tests, inform your doctor that they are taking <strong>Mixif</strong><sup>&Ograve;</sup>, as it can alter the results of some of these tests.</p><p><strong>Mixif</strong><sup>&Ograve;</sup> can alter the results of some urine tests for sugar (such as Benedict&rsquo;s or Fehling&rsquo;s tests). If your child has diabetes and you routinely test their urine, tell your doctor. This is because other tests may have to be used to monitor diabetes while your child is taking this medicine.</p><p><strong>Mixif</strong><sup>&Ograve;</sup> may alter the results of a blood test for antibodies called the Coombs&rsquo; test.</p><p><strong>Taking other medicines herbal or dietary supplements </strong></p><p>Tell your doctor or pharmacist if your child is taking has recently taken or might take any other medicines. This includes medicines obtained without a prescription.</p><p><strong>Mixif</strong><sup>&Ograve;</sup> may increase the time it takes for blood to clot. This should be taken into account if your child is taking medicines to thin the blood such as warfarin.</p><p>Nifedipine, a medicine used to treat some heart conditions known as a calcium channel blocker, may increase the amount of <strong>Mixif</strong><sup>&Ograve;</sup> in the body.</p><p><strong>Pregnancy and breast-feeding </strong></p><p>This medicine is specially made for children but if you are taking it as an adult and you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, you must tell your doctor before taking this medicine.</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Driving and using machines </strong></p><p>Cefixime does not usually affect the ability to drive or use machines. However, if you are an adult taking <strong>Mixif</strong><sup>&Ograve;</sup> and feel light-headed or dizzy, do not drive or operate machinery. If your child feels light-headed or dizzy, they should not take part in any activities that may require concentration or present a safety risk e.g. riding a bike.</p><p>Each 5 ml of <strong>Mixif</strong><sup>&Ograve;</sup> contains 2.3 g sucrose:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have been told by your doctor that your child has an intolerance to some sugars, contact your doctor before giving this medicinal product.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This should be taken into account in patients with diabetes mellitus.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Also, this amount may be harmful to the teeth.</p><p>This medicine contains 5 mg sodium benzoate in each 5ml &nbsp;</p><p>Sodium benzoate in Mixif&Ograve; suspension may increase jaundice (yellowing of the skin and eyes) in newborn babies (up to 4 weeks old).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always give this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Your doctor will decide the right dose of <strong>Mixif</strong><sup>&Ograve;</sup> and how long it must be taken for. Do not stop giving your child <strong>Mixif</strong><sup>&Ograve;</sup> early even if their symptoms improve, otherwise the infection might come back.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This medicine can be given as a single dose or in two divided doses each day.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your doctor has prescribed one dose a day, it should be given every 24 hours.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your doctor has prescribed two doses a day, each dose should be given every 12 hours, one dose in the morning and the other in the evening. The medicine should always be given at the same time each day.</p><p><strong>The recommended dose is: </strong></p><p><strong><em>Adults, and children over 10 years of age or who weigh more than 50 kg</em></strong>: The recommended dose is 200-400 mg of <strong>Mixif</strong><sup>&Ograve;</sup> daily. The correct dose is given using the syringe provided and pulling the top ring up to the 10 ml mark once to give a dose of 200mg and 2 times to give a dose of 400mg. <strong>Mixif</strong><sup>&Ograve;</sup> may be taken with or without food.</p><p><strong><em>Elderly</em></strong>: For elderly patients, the doses are the same as adults provided that your kidney function is normal.</p><p><strong><em>Children less than 10 years of age</em></strong>: The dose depends on your child&rsquo;s weight. Your doctor will prescribe the correct amount to give to your child. The usual dose is 8mg/kg daily.</p><p>The following table describes a range of paediatric dosage according to the weight of the child:</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Child&rsquo;s weight</strong></p></td><td style="vertical-align:top"><p><strong>Daily dose</strong></p></td><td style="vertical-align:top"><p><strong>Daily dose according to the syringe graduations</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>5 kg</strong></p></td><td style="vertical-align:top"><p>40 mg</p></td><td style="vertical-align:top"><p>2 ml (once daily) or 1 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>10 kg</strong></p></td><td style="vertical-align:top"><p>80 mg</p></td><td style="vertical-align:top"><p>4 ml (once daily) or 2 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>12.5 kg</strong></p></td><td style="vertical-align:top"><p>100 mg</p></td><td style="vertical-align:top"><p>5 ml (once daily) or 2.5 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>15 kg</strong></p></td><td style="vertical-align:top"><p>120 mg</p></td><td style="vertical-align:top"><p>6 ml (once daily) or 3 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>17.5 kg</strong></p></td><td style="vertical-align:top"><p>140 mg</p></td><td style="vertical-align:top"><p>7 ml (once daily) or 3.5 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>20 kg</strong></p></td><td style="vertical-align:top"><p>160 mg</p></td><td style="vertical-align:top"><p>8 ml (once daily) or 4 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>22.5 kg</strong></p></td><td style="vertical-align:top"><p>180 mg</p></td><td style="vertical-align:top"><p>9 ml (once daily) or 4.5 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>25 kg</strong></p></td><td style="vertical-align:top"><p dir="RTL">200 mg</p></td><td style="vertical-align:top"><p dir="RTL">&nbsp;10 ml (once daily) or 5 ml (twice daily)</p></td></tr></tbody></table><p><strong><em>Patients with kidney problems</em></strong>: In adults with kidney problems, the dose of Cefixime can be reduced. Your doctor will tell you exactly how much to take according to the results of blood or urine tests that measure how well your kidneys are working and also according to the severity of your infection. <strong>Mixif</strong><sup>&Ograve;</sup> is not recommended to be given to children and adolescents with kidney problems.</p><p><strong><em>Children less than 6 months of age</em></strong>: <strong>Mixif</strong><sup>&Ograve;</sup> should not be given to children under 6 months of age.</p><p>The medicine comes with a 10 ml syringe (pipette).</p><p>1 ml on the syringe corresponds to 20 mg of cefixime. The syringe should be used to measure the exact amount of medicine you need to give.</p><p>The dosing syringe enclosed indicates the dose recommended based on once daily dosing, refer to the table above for twice daily dosing and always follow the doctor&rsquo;s recommendations.</p><p><strong>For reconstitution: </strong></p><p>Invert the bottle and shake content to loosen powder, add pre-boiled cooled water to the mark, and shake well, then add more water if necessary up to the mark and shake well until a homogenous suspension is obtained.</p><p>When first reconstituted, allow to stand for five minutes to insure full dispersion.</p><p>Shake well before use. &nbsp;</p><p><strong>If you give your child more Mixif</strong><sup>&Ograve;</sup><strong> than you should </strong></p><p>Contact your doctor or nearest hospital <strong>immediately</strong>. Take the container with you.</p><p><strong>If you forget to give Mixif</strong><sup>&Ograve;</sup><strong> to your child </strong></p><p>Give the next dose as soon as you remember unless it is almost time for the next dose.</p><p><strong>Do not </strong>give a double dose to make up for a forgotten dose.</p><p><strong>If you stop giving Mixif</strong><sup>&Ograve;</sup><strong> to your child </strong></p><p>Do not stop giving <strong>Mixif</strong><sup>&Ograve;</sup> because your child feels better. It is important for the dose to be taken for as long as your doctor has prescribed, otherwise the infection might come back.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>If any of the following happen, <strong>stop giving </strong><strong>Mixif</strong><sup>&Ograve;</sup> and tell your doctor <strong>immediately </strong>or go to your nearest hospital emergency department:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe diarrhoea with blood in the stools, stomach pain and fever during or after taking <strong>Mixif</strong><sup>&Ograve;</sup>. This may be something called pseudomembranous colitis and may occur over two months after treatment with <strong>Mixif</strong><sup>&Ograve;</sup> has stopped.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dark urine, pale stools, jaundice (yellowing of the skin and/or eyes), nausea, fever which may be due to problems with the liver</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the kidney causing lower back pain and difficulty in passing water, fever and feeling sick with weight loss, which may lead to kidney failure.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reactions including rashes have been reported with Cefixime. In very rare cases, difficulty in breathing, fainting and swelling of the face and throat can occur which may need emergency treatment. Allergic rashes may range in severity from mild itchy skin eruptions to a rarer, more serious condition called Stevens-Johnson syndrome (which may cause ulceration of the mouth, lips and skin) or toxic epidermal necrolysis (which causes severe illness and peeling of the skin).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Infections. Having a course of <strong>Mixif</strong><sup>&Ograve;</sup> can increase the chance that your child gets other types of infection</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increases in the numbers of new infections that your child gets, such as sore throat, or mouth ulcers, with a fever and/or feeling breathless and you notice that it takes longer than usual for their blood to clot, which may be due to a decrease in the numbers of different types of cell within the blood.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your child may feel tired and breathless with possible yellowing of the skin, which may be due to destruction of red blood cells.</p><p>In the unlikely event that your child&rsquo;s infection has been caused by a bug which <strong>Mixif</strong><sup>&Ograve;</sup> cannot treat, the symptoms may get worse. If this happens, you should consult your doctor.</p><p><strong>Other possible side effects: </strong></p><p><strong>Common (may affect up to 1 in 10 people): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diarrhoea</p><p><strong>Uncommon (may affect up to 1 in 100 people): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nausea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vomiting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stomach (abdominal pain)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in blood tests that show how your liver is working</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin rash</p><p><strong>Rare (may affect up to 1 in 1,000 people): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; loss of appetite (anorexia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flatulence (wind)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in blood tests that show how your kidney is working</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness or a feeling of spinning (vertigo)&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy skin</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the lining of the mouth and/or internal surfaces</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in blood tests that show an increase in some white blood cells</p><p><strong>Very rare (may affect up to 1 in 10,000 people): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; restlessness and increased activity</p><p><strong>Not known (frequency cannot be estimated from the available data): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irritation of the male or female sexual organs which may be caused by infection. feeling breathless</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood tests that may show changes in the level of bilirubin in the blood</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; indigestion</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; joint pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; puffiness of the face</p><p>If your child gets any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep medicament out of reach and sight of children.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 30&deg;C. Discard unused portion 14 days after reconstitution.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use <strong>Mixif</strong><strong><sup>&Ograve;</sup></strong><strong> </strong>suspension after the expiry date which is stated on the pack after EXP. The expiry date refers to the last day of that month.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>The active substance is</strong> cefixime (as cefixime trihydrate). After reconstitution each 5 ml contains 100 mg cefixime (as cefixime trihydrate). &nbsp;</p><p><strong>The other ingredients are: </strong>Sodium benzoate, silica colloidal anhydrous, xanthan gum, sucrose, tutti frutti flavor.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Mixif suspension is available in bottles for preparing 30 ml or 60 ml flavored suspensions. These bottles contain off white to yellowish powder. After reconstitution, the suspension is homogenous white to yellowish white. 
Comes with a measuring syringe that can measure 10 ml. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dar Al Dawa Development &amp; Investment Co. Ltd.</p><p>Prince Hashem Bin Al-Hussein Street.</p><p>Na&rsquo;ur &ndash; Amman &ndash; Jordan</p><p>Tel. (+962 6) 57 27 132</p><p>Fax. (+962 6) 57 27 776</p><p><strong>To report any side effects:</strong></p><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Jordan</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>o&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; Contact marketing authorization holder</p></td></tr></tbody></table><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>-&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>-&nbsp;&nbsp;&nbsp; Call NPC at +966- 11-2038222, Ext 2317, 2356, 2340</p><p>-&nbsp;&nbsp;&nbsp; SFDA Call Centre: 19999</p><p>-&nbsp;&nbsp;&nbsp; Email: npc.drug@sfda.gov .sa</p><p>-&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov .sa/</p></td></tr></tbody></table><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United Arab Emirates</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmacovigilance and Medical Device Section</p><p>-&nbsp;&nbsp;&nbsp; Drug Department</p><p>-&nbsp;&nbsp;&nbsp; UAE Ministry of Health &amp; Prevention</p><p>-&nbsp;&nbsp;&nbsp; Hotline: 80011111</p><p>-&nbsp;&nbsp;&nbsp; Email: pv@moh.gov.ae</p><p>-&nbsp;&nbsp;&nbsp; P.O. Box: 1853 Dubai UAE</p></td></tr></tbody></table><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Sudan</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>o&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; National Medicines and Poisons Board (NMPB)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Fax: + 249 183522263</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; E-mail: info@nmpb.gov.sd</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Website : www.nmpb.gov.sd</p></td></tr></tbody></table><p><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Other countries</strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>o&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                09/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي <strong>ميكسيف</strong> إلى مجموعة من الأدوية تدعى السيفالوسبورينات، وهي مضادات حيوية تستخدم لعلاج العدوى التي تسببها البكتيريا.</p><p dir="RTL">يستخدم <strong>ميكسيف</strong> في علاج:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الأذن الوسطى</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الجيوب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الحلق</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العدوى التي تسبب تفاقم مفاجئ في إلتهاب القصبات الهوائية المزمن</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الرئة الخطير (مثل الإلتهاب الرئوي) المكتسب من خارج المستشفى</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى المسالك البولية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الكلى</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يمنع</strong><strong> </strong><strong>إعطاء</strong><strong> </strong><strong>معلق ميكسيف </strong><strong>لطفلك في حال:</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان طفلك يعاني من حساسية تجاه سفكسيم، أو تجاه أي من المكونات الأخرى لهذا الدواء (المذكورة في القسم 6)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان طفلك يعاني من حساسية تجاه مضادات حيوية أخرى من مجموعة السيفالوسبورين.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سبق وأصيب طفلك برد فعل تحسسي شديد تجاه البنسلينات أو أي نوع آخر من المضادات الحيوية من مجموعة البيتا لاكتام.</p><p dir="RTL">الطفل المولود قبل أوانه أو الخديج حديث ولادة الذي لا يتجاوز عمره شهر واحد.</p><p dir="RTL"><strong>المحاذير والاحتياطات</strong><strong> </strong></p><p dir="RTL">تحدث إلى الطبيب أو الصيدلي قبل إعطاء هذا الدواء لطفلك إذا:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان طفلك يعاني من حساسية خفيفة إلى متوسطة تجاه المضادات الحيوية من مجموعة البنسلينات أو أي نوع آخر من المضادات الحيوية من مجموعة البيتا لاكتام. ليس بالضرورة أن يكون لدى الأشخاص المصابين بحساسية تجاه البنسلينات حساسية أيضاً تجاه السيفالوسبورينات. على الرغم من ذلك يجب اخذ الحيطة والحذر حيث أنه من الممكن أن يكون لدى طفلك حساسية من هذا الدواء أيضاً.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان طفلك&nbsp; يعاني من أي مشكلة في الكلى فإنه لا ينصح بإعطائه <strong>ميكسيف</strong>.</p><p dir="RTL">قد يقلل الطبيب الجرعة لدى المرضى البالغين الذين يعانون من مشاكل في الكلى.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سبق وتعرض لنقص في خلايا الدم الحمراء سبب اصفرار في الجلد وضعف أو ضيق في التنفس (فقر الدم الانحلالي) نتيجة لإعطائه مضادات حيوية من مجموعة السيفالوسبورين</p><p dir="RTL"><u>أثناء العلاج</u></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أصيب طفلك بإسهال شديد أو مستمر، والذي قد يحتوي على دم مصحوب بآلام في المعدة أو تقلصات، خلال أو بعد العلاج <strong>بميكسيف</strong> بفترة قصيرة، توقف عن اعطائه الدواء وأخبر الطبيب على الفور. وتجنب اعطائه الادوية التي تبطئ أو تثبط حركة الأمعاء في هذه الحالة.&nbsp;&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أخبر الطبيب أو الصيدلي في حال شعر طفلك بضيق في التنفس، مع اصفرار في الجلد والعينين قد ينتج ذلك عن تحلل خلايا الدم الحمراء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أصيب طفلك بحمى مصحوبة بآلام أسفل الظهر ومشاكل في التبول، عندها يجب عليك التوقف عن إعطائه الدواء وأخذه إلى الطبيب على الفور.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا أصيب طفلك بحمى، التهاب في الحلق، طفح مع بثور أو تقرحات في اي من الفم، الوجه، الجسم، الذراعين أو السيقان، عليك التوقف عن إعطائه الدواء وأخذه إلى الطبيب على الفور.</p><p dir="RTL"><u>التأثير على الفحوصات المخبرية </u></p><p dir="RTL">إذا لزم إجراء فحوصات مخبرية للدم أو للبول لطفلك، عليك إعلام الطبيب أن طفلك يتناول <strong>ميكسيف</strong>، حيث أنه من الممكن أن يتداخل في نتائج بعض هذه الفحوصات.</p><p dir="RTL">من الممكن أن يغير <strong>ميكسيف </strong>من نتائج فحوصات البول التي تكشف عن السكر (مثل فحوصات بندكت وفهلنج). يجب أن تخبر الطبيب إذا كان طفلك مصاب بالسكري ويلزمه فحوصات للبول بشكل دوري. وذلك لأنه من الممكن أن يلزمه إجراء فحوصات أخرى لمراقبة السكري أثناء تناوله لهذا الدواء.</p><p dir="RTL">كما من الممكن أن يغير <strong>ميكسيف</strong> من نتيجة الفحص الذي يكشف عن الأجسام المضادة، والذي يدعى اختبار كومبس.</p><p dir="RTL"><strong>التداخلات الدوائية من أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">أخبر الطبيب او الصيدلي إذا كان طفلك يتناول أو تنناول مؤخرا أو قد يتناول أي أدوية أخرى. يتضمن ذلك الأدوية التي تؤخذ من دون وصفة طبية.</p><p dir="RTL">من الممكن أن يزيد <strong>ميكسيف</strong> من المدة الزمنية التي يستغرقها الدم للتخثر. يجب أن يؤخذ ذلك بعين الاعتبار إذا كان طفلك يتناول أدوية لتمييع الدم مثل الوارفارين.</p><p dir="RTL">قد يزيد دواء نفيديبين (مثبط قنوات الكالسيوم ويستخدم لعلاج بعض مشاكل القلب) من كمية <strong>ميكسيف</strong> في الجسم.</p><p dir="RTL"><strong>الحمل</strong><strong> </strong><strong>والرضاعة </strong></p><p dir="RTL">إن هذا الدواء مخصص للأطفال لكن إذا كنتِ تتناولينه كشخص بالغ وكنتِ حامل أو مرضعة، تعتقدين أنك حامل أو تخططين للحمل، عليك إخبار الطبيب قبل أخذ الدواء.</p><p dir="RTL">اطلبي نصيحة الطبيب أو الصيدلي قبل تناول اي دواء.</p><p dir="RTL"><strong>القيادة واستخدام الآلات </strong></p><p dir="RTL">من غير المرجح أن يؤثر سفكسيم على قدرتك على القيادة أواستخدام الآلات.</p><p dir="RTL">على الرغم من ذلك، إذا كنت شخص بالغ و تناولت <strong>ميكسيف</strong> وشعرت بخفة في الرأس أو دوران، لا تقم بالقيادة أو استخدام الآلات. إذا شعر طفلك بخفة في الرأس أو دوران، عندها يجب أن تمنعه من أن يشارك في الانشطة التي تتطلب التركيز أو تشكل خطر على السلامة مثل قيادة الدراجات.</p><p dir="RTL">تحتوي كل 5 مل من معلق<strong> ميكسيف</strong> على 2.3 غرام سكر:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا أخبرك الطبيب بأن طفلك لا يمتلك القدرة على تحمل بعض أنواع السكر، إستشر الطبيب قبل إعطائه هذا الدواء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; يجب أخذ ذلك بعين الإعتبار لدى المرضى الذين يعانون من مرض السكري</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; كما من الممكن أن تكون لهذه الكمية تأثيراً ضاراً على الأسنان.</p><p dir="RTL">يحتوي معلق ميكسيف على 5 ملغم بنزوات الصوديوم في كل 5 مل.</p><p dir="RTL">من الممكن أن تزيد بنزوات الصوديوم&nbsp; في معلق <strong>ميكسيف</strong> ، فرصة حدوث يرقان لدى حديثي الولادة (الأقل من عمر 4 أسابيع).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">قم بإعطاء هذا الدواء الى طفلك حسب تعليمات الطبيب تماما. عليك التحقق من الطبيب أو الصيدلي إذا لم تكن متأكداً. سيقوم الطبيب بتحديد الجرعة المناسبة من <strong>ميكسيف</strong> والمدة الزمنية اللازمة لإتمام العلاج. لا تتوقف عن إعطاء <strong>ميكسيف</strong> لطفلك مبكراً حتى لو تحسنت حالته، لأنه من الممكن أن تتكرر إصابته بالعدوى مجدداً.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من الممكن أن يعطى هذا الدواء كجرعة واحده يوميا أو يقسم على جرعتين في اليوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا حدد الطبيب جرعة واحدة يومياً، فإنه يجب إعطائها كل 24 ساعة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا حدد الطبيب جرعتين يومياً، فإنه يجب إعطاء جرعة كل 12 ساعة، جرعة في الصباح وأخرى في المساء. ينبغي إعطاء هذا الدواء في نفس الوقت كل يوم.</p><p dir="RTL"><strong>الجرعات الموصى بها: &nbsp;</strong></p><p dir="RTL"><strong>البالغين والأطفال الذين تزيد أعمارهم عن 10 سنوات أو يزيد وزنهم عن 50 كغم: </strong>الجرعة الموصى بها هي 200 -400 ملغم من <strong>ميكسيف</strong> يوميا. تقاس الجرعة الصحيحة بواسطة اداة الجرعة المرفقة عن طريق سحب القرص إلى علامة 10 مل مرة واحدة لإعطاء جرعة 200 ملغم ومرتين لإعطاء جرعة 400 ملغم. من الممكن إعطاء <strong>ميكسيف</strong> مع أو بدون طعام.</p><p dir="RTL"><strong>كبار السن:</strong> يعطى كبار السن نفس جرعة البالغين في حال كانت وظائف الكلى لديهم طبيعية.</p><p dir="RTL"><strong>الاطفال الذين تقل اعمارهم عن 10 سنوات:</strong> تعتمد الجرعة على وزن طفلك. سيحدد الطبيب الكمية المناسبة لإعطائها لطفلك. الجرعة الإعتيادية هي 8 ملغم/كغم يومياً.</p><p dir="RTL">يوضح الجدول التالي جرعات الأطفال اعتمادا على الوزن:</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>الجرعة اليومية اعتمادا على تدريجات الحقنة</strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>الجرعة اليومية</strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>وزن الطفل </strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>2 مل (مرة يوميا) او 1 مل (مرتين يوميا)</strong></p></td><td style="vertical-align:top"><p dir="RTL">40 ملغم</p></td><td style="vertical-align:top"><p dir="RTL"><strong>5 كغم</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>4 مل (مرة يوميا) او 2 مل (مرتين يوميا)</strong></p></td><td style="vertical-align:top"><p dir="RTL">80 ملغم</p></td><td style="vertical-align:top"><p dir="RTL"><strong>10 كغم</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>5 مل (مرة يوميا) او 2.5 مل (مرتين يوميا)</strong></p></td><td style="vertical-align:top"><p dir="RTL">100 ملغم</p></td><td style="vertical-align:top"><p dir="RTL"><strong>12.5 كغم</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>6 مل (مرة يوميا) او 3 مل (مرتين يوميا)</strong></p></td><td style="vertical-align:top"><p dir="RTL">120 ملغم</p></td><td style="vertical-align:top"><p dir="RTL"><strong>15 كغم</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>7 مل (مرة يوميا) او 3.5 مل (مرتين يوميا)</strong></p></td><td style="vertical-align:top"><p dir="RTL">140 ملغم</p></td><td style="vertical-align:top"><p dir="RTL"><strong>17.5 كغم</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>8 مل (مرة يوميا) او 4 مل (مرتين يوميا)</strong></p></td><td style="vertical-align:top"><p dir="RTL">160 ملغم</p></td><td style="vertical-align:top"><p dir="RTL"><strong>20 كغم</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>9 مل (مرة يوميا) او 4.5 مل (مرتين يوميا)</strong></p></td><td style="vertical-align:top"><p dir="RTL">180 ملغم</p></td><td style="vertical-align:top"><p dir="RTL"><strong>22.5 كغم</strong></p></td></tr><tr><td style="vertical-align:top"><p dir="RTL"><strong>10 مل (مرة يوميا) او 5 مل (مرتين يوميا)</strong></p></td><td style="vertical-align:top"><p dir="RTL">200 ملغم</p></td><td style="vertical-align:top"><p dir="RTL"><strong>25 كغم</strong></p></td></tr></tbody></table><p dir="RTL"><strong>المرضى المصابين بمشاكل في الكلى: </strong>في المرضى البالغين المصابين بمشاكل في الكلى، من الممكن تقليل جرعة سفكسيم. سيخبرك الطبيب بالجرعة المناسبة بناءاً على نتائج فحوصات الدم والبول التي تكشف عن حالة الوظيفة الكلوية بالإضافة إلى شدة العدوى لديك. لا يوصى بإعطاء <strong>ميكسيف</strong> للأطفال واليافعين المصابين بمشاكل في الكلى.</p><p dir="RTL"><strong>الاطفال دون عمر 6 اشهر:</strong> يمنع إعطاء <strong>ميكسيف</strong> للأطفال الذين تقل أعمارهم عن 6 أشهر.</p><p dir="RTL">يتوفر هذا الدواء مع اداة جرعة سعتها 10 مل.</p><p dir="RTL">كل 1 مل من الحقنة تعادل 20 ملغم من سفكسيم. تستخدم الحقنة لحساب الجرعة الدقيقة من الدواء اللازمة لإعطائها.</p><p dir="RTL">تشير الحقنة المرفقة إلى الجرعة الموصى بإعطائها مرة واحدة يومياً، راجع الجدول السابق لمعرفة الجرعات للاستخدام مرتين يومياً. اتبع ارشادات الطبيب دائماً.</p><p dir="RTL"><strong>لتجهيز المعلق: </strong></p><p dir="RTL">اقلب القارورة مع رج المحتوى لتفكيك البودرة، أضف الماء المغلي والمبرد الى العلامة ثم خض القارورة جيداً وأكمل بالماء إلى العلامة إن لزم، اعد رج القارورة جيداً حتى يتم الحصول على معلق متجانس. عند تحضير المعلق لأول مرة يترك لمدة خمس دقائق للتأكد من تجانسه تماماً.</p><p dir="RTL">رج القارورة جيداً قبل الاستعمال.</p><p dir="RTL"><strong>الجرعة</strong><strong> </strong><strong>الزائدة</strong><strong> </strong><strong>من</strong><strong> </strong><strong>معلق ميكسيف </strong></p><p dir="RTL">تواصل مع الطبيب أو أقرب مستشفى <strong>على الفور</strong>، وخذ علبة الدواء معك.</p><p dir="RTL"><strong>نسيان</strong><strong> </strong><strong>إعطاء</strong><strong> </strong><strong>جرعة</strong><strong> </strong><strong>معلق ميكسيف </strong></p><p dir="RTL">ينبغي عليك<strong> </strong>إعطاء طفلك الجرعة الفائتة فور تذكرك إلا في حال اقتراب موعد الجرعة التالية.</p><p dir="RTL"><strong>لا</strong> تضاعف الجرعة للتعويض عن الجرعة الفائتة.</p><p dir="RTL"><strong>التوقف عن إعطاء معلق ميكسيف لطفلك </strong></p><p dir="RTL">لا تتوقف عن إعطاء <strong>ميكسيف</strong> لطفلك إذا شعر بتحسن. من الضروري أن تعطى الجرعات طوال الفترة الزمنية التي حددها الطبيب، لأنه من الممكن أن تتكرر العدوى مجدداً.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى تتعلق بإستخدام هذا الدواء، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن الأدوية الأخرى من الممكن أن يسبب هذا الدواء بعض التأثيرات الجانبية، إلا أنها لا تحدث عند الجميع.</p><p dir="RTL"><strong>توقف عن إعطاء</strong> <strong>ميكسيف</strong> وتحدث إلى الطبيب <strong>على الفور</strong> أو راجع أقرب قسم طوارئ إذا حدثت أي من التأثيرات الجانبية التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اسهال شديد وبراز محتوي على دم، ألم في المعدة وحمى أثناء تناول <strong>ميكسيف</strong>. من الممكن أن تكون بسبب حدوث إلتهاب غشاء القولون الكاذب وقد تحدث حتى بعد شهرين من إيقاف العلاج <strong>بميكسيف</strong>.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;بول داكن اللون، أو براز لونه فاتح، يرقان (اصفرار لون الجلد و/أو العينين)، غثيان، حمى والتي قد يسببها مشاكل في الكبد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إلتهاب في الكلى يؤدي إلى آلام في الظهر وصعوبة في التبول، حمى وغثيان مع فقدان في الوزن، والذي قد يؤدي إلى فشل كلوي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تم الإبلاغ عن تفاعلات حساسية تتضمن طفح من استخدام سفكسيم. في حالات نادرة جداً، من الممكن أن يحدث صعوبة في التنفس، إغماء وانتفاخ في الوجه والحلق والذي من الممكن أن يتطلب علاج طارئ. قد يتراوح الطفح التحسسي في شدته من تهيج في الجلد مع حكة خفيفة إلى حالة نادرة وأكثر خطراً تدعى متلازمة ستيفن جونسون (والتي قد تسبب تقرحات في الفم، الشفاه أو الجلد) أو حالة أخرى تدعى تحلل البشرة السمي (والذي قد يسبب تعب شديد بالإضافة إلى تقشر في الجلد).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإصابة بعدوى. قد يؤدي العلاج <strong>بميكسيف</strong> إلى زيادة فرصة إصابة طفلك بعدوى أخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كثرة أنواع العدوى الجديدة التي من الممكن أن تصيب طفلك، على سبيل المثال إلتهاب الحلق، أو تقرحات الفم، مع حمى و/أو الشعور بضيق في النفس مع ملاحظة زيادة المدة الزمنية التي يحتاجها الدم كي يتخثر، والتي قد يكون سببها نقصان عدد أنواع الخلايا في الدم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يشعر طفلك بتعب وضيق في النفس مع احتمالية اصفرار جلده، والذي قد يكون بسبب تحلل خلايا الدم الحمراء.</p><p dir="RTL">في حال كان سبب العدوى لدى طفلك جرثومة، لا يستطيع <strong>ميكسيف</strong> علاج هذه الحالة، وهذا غير مرجح من الممكن أن تتفاقم الأعراض المرضية لديه. إذا حدث ذلك، عليك استشارة الطبيب على الفور.</p><p dir="RTL"><strong>الأعراض الجانبية الأخرى المحتملة: </strong></p><p dir="RTL"><strong>شائعة (قد تؤثر على شخص واحد من كل 10 أشخاص كحد أقصى): </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال</p><p dir="RTL"><strong>غير شائعة (قد تؤثر على شخص واحد من كل 100 شخص كحد أقصى): </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غثيان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقيؤ</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الم في المعدة &nbsp;(ألم في البطن)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في نتائج فحوصات الدم التي تكشف عن وظائف الكبد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي</p><p dir="RTL"><strong>نادرة (قد تؤثر على شخص واحد من كل 1000 شخص كحد أقصى): </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتفاخ (ريح)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في نتائج فحوصات الدم التي تكشف عن وظائف الكلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوخة أو الشعور بدوار</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة في الجلد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إلتهاب في بطانة الفم و/أو الأسطح الداخلية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في نتائج فحوصات الدم التي تظهر ارتفاع في بعض خلايا الدم البيضاء</p><p dir="RTL"><strong>نادرة جداً (قد تؤثر على شخص واحد من كل 10000 شخص كحد أقصى): </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هياج نفسي حركي وزيادة النشاط</p><p dir="RTL"><strong>غير معروفة (لا يمكن تحديد تكرارها بناءاً على البيانات المتاحة): </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اهتياج الأعضاء التناسلية لدى الذكور والإناث والذي قد يحدث بسبب عدوى. الشعور بضيق في النفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فحوصات مخبرية للدم تظهر تغير في مستويات البيليروبين في الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عسر الهضم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم المفاصل</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>انتفاخ الوجه</p><p dir="RTL">إذا أصيب طفلك بأي عرض جانبي، أخبر الطبيب أو الصيدلي أو الممرض. يتضمن ذلك أي أعراض جانبية محتملة لم يتم ذكرها في هذه النشرة.&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدا عن متناول أيدي الأطفال ونظرهم.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ على درجة حرارة لا تزيد عن 30 درجة مئوية. لا تستعمل اي كمية متبقية بعد 14 يوم من تجهيز المعلق.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم معلق<strong> ميكسيف</strong> بعد تاريخ الإنتهاء المذكور على العبوة الخارجية بعد EXP. يدل تاريخ الإنتهاء على آخر يوم في الشهر المذكور.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية في المياه العادمة أو النفايات المنزلية. اسأل الصيدلي حول الطريقة السليمة للتخلص من الادوية التي لم تعد بحاجة اليها. سيساعد هذا في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>المادة الفعالة</strong> <strong>هي</strong> سفكسيم على (هيئة سفكسيم ثلاثي الماء). بعد تجهيز المعلق، تحتوي كل 5 مل على 100 ملغم سفكسيم (على هيئة سفكسيم ثلاثي الماء).</p><p dir="RTL"><strong>المواد غير الفعالة الأخرى:</strong> بنزوات الصوديوم، سيليكا غروية لامائية، صمغ الزانثان، سكر، نكهة توتي فروتي.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ما</strong><strong> </strong><strong>هو</strong><strong> </strong><strong>الشكل</strong><strong> </strong><strong>الصيدلاني</strong><strong> </strong><strong>لمعلق ميكسيف ووصفه</strong><strong> </strong><strong>وحجم</strong><strong> </strong><strong>عبوته</strong></p><p dir="RTL">يتوفر مسحوق <strong>ميكسيف</strong> لتجهيز معلق فموي في قوارير لتجهيز معلق 30 مل أو 60 مل من المعلق المنكه. تحتوي القارورة على مسحوق لونه مائل للبياض إلى الأصفر. بعد التجهيز، يكون المعلق متجانس لونه أبيض إلى أبيض مصفر.</p><p dir="RTL">تحتوي العبوة أيضاً على حقنة سعتها 10 مل لقياس الجرعة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة دار الدواء للتنمية والإستثمار المساهمة المحدودة</p><p dir="RTL">شارع الأمير هاشم بن الحسين</p><p dir="RTL">ناعور &ndash; عمان &ndash; الأردن</p><p dir="RTL">هاتف. 132 27 57 (6 962 +)</p><p dir="RTL">فاكس.776 27 57 (6 962 +)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن الأعراض الجانبية:</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأردن</strong></p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرجاء الإتصال بمالك رخصة التسويق</p></td></tr></tbody></table><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المملكة العربية السعودية</strong></p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ والسلامة الدوائية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فاكس: 112057662 966 +</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتصل بالمركز الوطني للتيقظ والسلامة الدوائية على الرقم:</p><p dir="RTL">112038222 966 +، فرعي: 2317-2356-2340</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرقم الموحد 19999</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الالكتروني https://ade.sfda.gov.sa/ :</p></td></tr></tbody></table><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإمارات العربية المتحدة</strong></p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قسم اليقظة الدوائية والوسائل الطبية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إدارة الدواء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وزارة الصحة ووقاية المجتمع</p><p dir="RTL">&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الخط الساخن : ٨٠٠١١١١١</p><p dir="RTL">&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ايميل : pv@moh.gov.ae</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صندوق بريد : ١٨٥٣ دبي الامارات العربية المتحدة</p></td></tr></tbody></table><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السودان</strong></p><table dir="rtl" border="0" cellspacing="0" cellpadding="0" style="width:548px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المجلس القومي للأدوية والسموم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فاكس: 183522263 249+</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: info@nmpb.gov.sd</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: www.nmpb.gov.sd</p></td></tr></tbody></table><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدول الأخرى</strong></p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            09/2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Mixif® 100 mg Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The active substance is cefixime (as cefixime trihydrate).
Each 5 ml (teaspoonful) contains 100 mg cefixime (as cefixime trihydrate).
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                These bottles contain off white to yellowish powder.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mixif&reg; is an orally active cephalosporin antibiotic which has marked in vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms.<br />Cefixime is indicated for the treatment of the following infections when caused by susceptible organisms:<br />&bull; Acute exacerbations of chronic bronchitis<br />&bull; Community-acquired Pneumonia<br />&bull; Lower urinary tract infections<br />&bull; Pyelonephritis<br />&bull; Otitis media<br />&bull; Sinusitis<br />&bull; Pharyngitis<br />The use of Cefixime should be reserved for infections where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk.<br />Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults and children over 10 years of age (body weight is greater than 50 kg)<br />The recommended dose is 200-400 mg daily according to the severity of the infection, given either as a single dose or in two divided doses.<br />Elderly patients<br />Elderly patients may be given the same dose as recommended for adults. Renal function should be assessed and dosage should be adjusted in severe impairment (See dosage for renal impairment and section 4.4).<br />Children younger than 10 years of age (body weight is lower than 50 kg) &ndash;<br />Paediatric Oral Suspension<br />The recommended dosage for children is 8 mg/kg/day administered as a single dose or in two divided doses. The following table describes a range of paediatric dosage according to the weight of the child:<br />Children weighing more than 50 kg or older than 10 years should be treated with the recommended adult dose (200 -400 mg daily), depending on the severity of the infection.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Child&rsquo;s weight</strong></p></td><td style="vertical-align:top"><p><strong>Daily dose</strong></p></td><td style="vertical-align:top"><p><strong>Daily dose according to the syringe graduations</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>5 kg</strong></p></td><td style="vertical-align:top"><p>40 mg</p></td><td style="vertical-align:top"><p>2 ml (once daily) or 1 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>10 kg</strong></p></td><td style="vertical-align:top"><p>80 mg</p></td><td style="vertical-align:top"><p>4 ml (once daily) or 2 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>12.5 kg</strong></p></td><td style="vertical-align:top"><p>100 mg</p></td><td style="vertical-align:top"><p>5 ml (once daily) or 2.5 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>15 kg</strong></p></td><td style="vertical-align:top"><p>120 mg</p></td><td style="vertical-align:top"><p>6 ml (once daily) or 3 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>17.5 kg</strong></p></td><td style="vertical-align:top"><p>140 mg</p></td><td style="vertical-align:top"><p>7 ml (once daily) or 3.5 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>20 kg</strong></p></td><td style="vertical-align:top"><p>160 mg</p></td><td style="vertical-align:top"><p>8 ml (once daily) or 4 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>22.5 kg</strong></p></td><td style="vertical-align:top"><p>180 mg</p></td><td style="vertical-align:top"><p>9 ml (once daily) or 4.5 ml (twice daily)</p></td></tr><tr><td style="vertical-align:top"><p><strong>25 kg</strong></p></td><td style="vertical-align:top"><p dir="RTL">200 mg</p></td><td style="vertical-align:top"><p dir="RTL">&nbsp;10 ml (once daily) or 5 ml (twice daily)</p></td></tr></tbody></table><p>Children weighing more than 50 kg or older than 10 years should be treated with the recommended adult dose (200 -400 mg daily), depending on the severity of the infection.<br />Children younger than 6 months of age<br />The safety and efficacy of cefixime has not been established in children less than 6 months.<br />Renal impairment<br />Cefixime may be administered in the presence of impaired renal function. Normal dose and schedule may be given in patients with creatinine clearance of 20 ml/ min or greater. In patients whose creatinine clearance is less than 20 ml/min, it is recommended that a dose of 200 mg once daily should not be exceeded. The dose and regimen for patients who are maintained on chronic ambulatory dialysis or haemodialysis should follow the same recommendation as that for patients with creatinine clearance of less than 20 ml/min.<br />Method of administration<br />Cefixime powder for oral suspension is for oral administration only.<br />The absorption of cefixime is not significantly affected by the presence of food.<br />Hence it can be administered with or without food. For instructions on reconstitution of the medicinal product before administration, see section 6.6.<br />Duration of treatment<br />The usual course of treatment is 7 days. In severe cases, this can be extended to 14 days.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Patients with known hypersensitivity to cephalosporin antibiotics or any of the other components of the product.
Cefixime is also contraindicated in patients with previous, immediate and/or severe hypersensitivity to penicillin or any beta-lactam antibiotics and preterm and term
newborn infants (0-27 days).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Severe cutaneous adverse reactions<br />Severe cutaneous adverse reactions such as toxic epidermal necrolysis, Stevens-Johnson syndrome and drug rash with eosinophilia and systemic symptoms (DRESS) have been reported in some patients on cefixime. When severe cutaneous adverse reactions occur, cefixime should be discontinued and appropriate therapy and/or measures should be taken.<br />Mixif&reg; should be given with caution to patients who have shown hypersensitivity to other drugs.<br />Hypersensitivity to penicillins<br />As with other cephalosporins, cefixime should be given with caution to patients with a history of hypersensitivity to penicillin, as there is some evidence of partial cross-allergenicity between the penicillins and cephalosporins.<br />Patients have had severe reactions (including anaphylaxis) to both classes of drugs. If severe hypersensitivity reactions or anaphylactic reactions occur after administration of Cefixime, the medicine should be discontinued immediately and appropriate emergency measures should be initiated.<br />Haemolytic anaemia<br />Drug-induced haemolytic anaemia, including severe cases with a fatal outcome, has been described for cephalosporins (as a class). The recurrence of haemolytic anaemia after re-administration of cephalosporins in a patient with a history of cephalosporin (including cefixime) &ndash;associated haemolytic anaemia has also been reported.<br />Antibiotic associated pseudomembreanous colitis produced by C. Difficile.<br />Prolonged use of cefixime may result in the overgrowth of non-susceptible organisms.<br />Treatment with a broad spectrum of antibiotics alters the normal flora of the colon and may permit the overgrowth of Clostridia. Studies indicate that a toxin produced by Clostridium difficile is a primary cause for antibiotic-associated diarrhoea.<br />Pseudomembranous colitis is associated with the use of broad-spectrum antibiotics (including macrolides, semi-synthetic penicillins, lincosamides and cephalosporins). It is therefore important to consider its diagnosis in patients who develop diarrhoea in association with the use of antibiotics.<br />In patients who develop severe diarrhoea during or after use of cefixime, the risk of life threatening pseudo-membranous colitis should be taken into account (see section 4.8). The use of cefixime should be discontinued and appropriate treatment measures should be established. Management of pseudomembranous colitis should include sigmoidoscopy, appropriate bacteriologic studies, fluids, electrolyte and protein supplementation. If the colitis does not improve after the drug has been discontinued or if the symptoms are severe, oral vancomycin is the drug of choice for antibiotic associated pseudomembreanous colitis produced by C. Difficile. Other causes of colitis should be excluded. The use of medicinal products inhibiting the intestinal peristalsis is contra-indicated.<br />Acute renal failure<br />As with other cephalosporins, cefixime may cause acute renal failure including tubulointerstitial nephritis as an underlying pathological condition. When acute renal failure occurs, cefixime should be discontinued and appropriate therapy and/or measures should be taken.<br />Use of Nifedipine, a calcium channel blocker, may increase bioavailability of Cefixime up to 70%.<br />Renal insufficiency<br />Cefixime should be administered with caution in adult patients with creatinine clearance &lt;20ml/min (see sections 4.2 and 5.2). There are insufficient data regarding use of cefixime in the pediatric and adolescent age group in the presence of renal insufficiency: the use of cefixime in these patient-groups is not recommended.<br />Paediatric use<br />Safety of cefixime in premature or newborn infant has not been established.<br />Mixif&reg; suspension contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucosegalactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Anticoagulants<br />In common with other cephalosporins, increases in prothrombin times have been noted in a few patients. Care should therefore be taken in patients receiving anticoagulation therapy.<br />Cefixime should be administered with caution to patients receiving coumarin-type anticoagulants, e.g. warfarin potassium. Since cefixime may enhance effects of the anticoagulants, prolonged prothrombin time with or without bleeding may occur.<br />In use with Nifedipine, a calcium channel blocker, may increase bioavailability of<br />Cefixime up to 70%.<br />Other forms of interaction<br />The administration of cephalsporins may interfere with the results of some laboratory<br />tests.<br />A false positive reaction for glucose in the urine may occur with Benedict&#39;s or Fehling&#39;s solutions or with copper sulphate test tablets, but not with tests based on enzymatic glucose oxidase reactions.<br />A false positive direct Coombs test has been reported during treatment with cephalosporin antibiotics, therefore it should be recognised that a positive Coombs test may be due to the drug.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />For cefixime, no clinical data on exposed pregnancies are available. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see section 5.3).<br />Caution should be exercised when prescribing to pregnant women. Cefixime should not be used in pregnant mothers unless considered essential by the physician.<br />Breast-feeding<br />It is unknown whether cefixime is excreted in human milk and non-clinical studies have shown excretion of cefixime in animal milk. A decision on whether to continue/discontinue breast-feeding or to continue/discontinue therapy with cefixime should be made taking into account<br />the benefit of breast-feeding to the child and the benefit of cefixime therapy to the woman. However, until further clinical experience is available, cefixime should not be prescribed to breast-feeding mothers.<br />Fertility<br />Animal studies do not indicate any harmful effects with respect to fertility, however, no clinical data are available</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefixime has no known influence on the ability to drive and use machines. However, side effects may occur (see section 4.8), which may influence the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefixime is generally well tolerated. The majority of adverse reactions observed in clinical trials were mild and self-limiting in nature.<br />Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.<br />The following undesirable effects have been divided in the following categories:<br />Very common: &gt;1/10<br />Common: &gt;1/100 to &lt;1/10<br />Uncommon: &gt;1/1,000 to &lt;1/100<br />Rare: &gt;1/10,000 to &lt;1/1,000<br />Very rare: &lt;1/10,000<br />Not known: cannot be estimated from the available data</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ</strong></p><p><strong>Class</strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>Adverse Reaction </strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>Frequency</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Infections and infestations</strong></p></td><td rowspan="2" style="vertical-align:top"><p>Superinfection bacterial,</p><p>superinfection fungal</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Blood and lymphatic</strong></p><p><strong>system disorders</strong></p></td><td style="vertical-align:top"><p>Eosinophilia</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Leucopenia, agranulocytosis,</p><p>pancytopenia,</p><p>thrombocytopenia, haemolytic anaemia</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td><td style="vertical-align:top"><p>Hypersensitivity</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Anaphylactic shock, serum</p><p>sickness</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p><strong>Metabolism and nutrition</strong></p><p><strong>disorders</strong></p></td><td style="vertical-align:top"><p>Anorexia</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td><td style="vertical-align:top"><p>Headache</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Vertigo, dizziness</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Psychomotor hyperactivity</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td><td style="vertical-align:top"><p>Diarrhoea*</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Abdominal pain, nausea,</p><p>vomiting</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Flatulence</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Cases of pseudomembraneous colitis</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary disorders </strong></p></td><td style="vertical-align:top"><p>Hepatitis, cholestatic jaundice</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Skin and subcutaneous</strong></p><p><strong>disorders</strong></p></td><td style="vertical-align:top"><p>Rash</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Angioneurotic oedema,</p><p>pruritus</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Stevens-Johnson Syndrome,</p><p>toxic epidermal necrolysis,</p><p>Lyell syndrome</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p><strong>Renal and urinary</strong></p><p><strong>disorders</strong></p></td><td style="vertical-align:top"><p>Interstitial nephritis</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p><strong>General disorders and</strong></p><p><strong>administration site</strong></p><p><strong>conditions</strong></p></td><td style="vertical-align:top"><p>Mucosal inflammation,</p><p>pyrexia</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Investigations</strong></p></td><td style="vertical-align:top"><p>Hepatic enzyme increased</p><p>(transaminase, alkaline</p><p>phosphatase)</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Blood urea increased</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Blood creatinine increased</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr></tbody></table><p>*Diarrhoea has been more commonly associated with higher doses. Some cases of moderate to severe diarrhoea have been reported; this has occasionally warranted cessation of therapy. Mixif&reg; should be discontinued if marked diarrhoea occurs.<br />To report any side effects:<br />National Pharmacovigilance &amp;amp; amp; Drug Safety Centre (NPC)<br />&bull; Fax: +966-11-205-7662<br />&bull; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />&bull; Toll free phone: 8002490000<br />&bull; E-mail: npc.drug@sfda.gov.sa<br />&bull; Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no experience with overdoses with cefixime.<br />Adverse reactions seen at dose levels up to 2 g cefixime in normal subjects did not differ from the profile seen in patients treated at the recommended doses. Cefixime is not removed from the circulation in significant quantities by dialysis.<br />No specific antidote exists. General supportive measures are recommended.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: antibacterial for systemic use, belonging to the class of<br />cephalsporins, ATC code: J01DD08.<br />Mode of action<br />Cefixime is an antibiotic belonging to the third-generation cephalosporin group. Like other cephalsporins, cefixime exerts antibacterial activity by binding to and inhibiting the action of penicillin-binding proteins involved in the synthesis of bacterial cell walls. This leads to bacterial cell lysis and cell death.<br />PK/PD Relationship<br />The time that the plasma concentration of cefixime exceeds the MIC of the infecting organism has been shown to best correlate with efficacy in PK/PD studies.<br />Mechanism of resistance<br />Bacterial resistance to cefixime may be due to one or more of the following mechanisms:<br />&bull; Hydrolysis by extended-spectrum beta-lactamases and/or by chromosomally-encoded<br />(AmpC) enzymes that may be induced or de-repressed in certain aerobic gramnegative bacterial species<br />&bull; Reduced affinity of penicillin-binding proteins<br />&bull; Reduced permeability of the outer membrane of certain gram-negative organisms restricting access to penicillin-binding proteins<br />&bull; Drug efflux pumps<br />More than one of these mechanisms of resistance may co-exist in a single bacterial cell. Depending on the mechanism(s) present, bacteria may express cross-resistance to several or all beta-lactams and/or antibacterial drugs of other classes.<br />Breakpoints<br />Clinical minimum inhibitory concentration (MIC) breakpoints established by EUCAST (May 2009) for cefixime are:<br />Breakpoints (MIC, mg/L)</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>Microorganism Susceptible (</strong>&le;<strong>)</strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>Susceptible (</strong>&le;<strong>) </strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>Resistant (&gt;)</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae </em></p></td><td style="vertical-align:top"><p>0.12 mg/L</p></td><td style="vertical-align:top"><p>0.12 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis </em></p></td><td style="vertical-align:top"><p>0.5 mg/L</p></td><td style="vertical-align:top"><p>1.0 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Neisseria gonorrhoeae </em></p></td><td style="vertical-align:top"><p>0.12 mg/L</p></td><td style="vertical-align:top"><p>0.12 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Enterobacteriaceae </em></p></td><td style="vertical-align:top"><p>1.0 mg/L</p></td><td style="vertical-align:top"><p>1.0 mg/L</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><em>Enterobacteriaceae</em>: For uncomplicated urinary tract infections only. The</p><p>breakpoints for <em>Enterobacteriaceae </em>will detect reduced susceptibility</p><p>mediated by most clinically important beta-lactamases in</p><p><em>Enterobacteriaceae</em>. Occassional ESBL-producing strains will be reported</p><p>susceptible. For purposes of infection control, epidemiology and</p><p>surveillance, laboratories may wish to use specific tests to screen for and</p><p>confirm ESBL-production.</p></td></tr><tr><td style="vertical-align:top"><p>Non-species related breakpoints</p></td><td colspan="2" style="vertical-align:top"><p>Insufficient data</p></td></tr></tbody></table><p>Susceptibility<br />The prevalence of resistance may vary geographically and over time for selected<br />species and local information on resistance is desirable, particularly when treating<br />severe infections. As necessary, expert advice should be sought when local<br />prevalence if resistance is such that the utility of the agent in at least some types of<br />infections is questionable.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Category 1: Commonly Susceptible organisms</strong></p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Aerobes, Gram-positive</strong></p></td><td style="vertical-align:top"><p><strong>Aerobes, Gram-negative</strong></p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae (</em>penicillinsusceptible)</p><p><em>Streptococcus pyogenes</em></p></td><td style="vertical-align:top"><p><em>Escherichia Coli</em><em>%</em></p><p><em>Haemophilus influenzae</em></p><p><em>Klebsiella species</em><em>%</em></p><p><em>Morexella catarrhalis</em></p><p><em>Proteus mirabilis</em><em>%</em></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Category 2: Organisms for which acquired resistance may be problematic</strong></p><p><em>Enterobacter </em>species</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Category 3: Resistant organisms</strong></p><p><em>Clostridium difficile</em></p><p><em>Bacteroides fragilis</em></p><p><em>Enterococci</em></p><p><em>Pseudomonas </em>species</p><p><em>Staphylococcus aureus</em><em>+</em></p><p><em>Streptococcus pneumoniae </em>(Penicillin resistant)</p><p><em>Enterobacter </em>species</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>% Extended spectrum beta-lactamase (ESBL) producing isolates are always</p><p>resistant</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>+ Cefixime has poor activity against staphylococci (regardless of susceptibility to</p><p>methicillin)</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />The absolute bioavailability of cefixime is in the range of 22-54%. Absorption is not<br />significantly modified by the presence of food. Cefixime may therefore be given<br />without regard for meals.<br />Distribution<br />Serum protein binding is well characterised for human and animal sera; cefixime is<br />almost exclusively bound to the albumin fraction, the mean free fraction being<br />approximately 30%. Protein binding of cefixime is only concentration dependent in<br />human serum at very high concentrations which are not seen following clinical<br />dosing.<br />From in vitro studies, serum or urine concentrations of 1 mg/L or greater were<br />considered to be adequate for most common pathogens against which cefixime is<br />active. Typically, the peak serum levels following the recommended adult or<br />paediatric doses are between 1.5 and 3 mg/L. Little or no accumulation of cefixime<br />occurs following multiple dosing.<br />Metabolism and elimination<br />Cefixime is predominantly eliminated as unchanged drug in the urine. Glomerular<br />filtration is considered the predominant mechanism. Metabolites of cefixime have not<br />been isolated from human serum or urine.<br />Transfer of 14C-labelled cefixime from lactating rats to their nursing offspring through<br />breast milk was quantitatively small (approximately 1.5% of the mothers&#39; body<br />content of cefixime in the pup). No data are available on secretion of cefixime in<br />human breast milk. Placental transfer of cefixime was small in pregnant rats dosed<br />with labelled cefixime.<br />Special age groups<br />The pharmacokinetics of cefixime in healthy elderly (aged &gt; 64 years) and young<br />volunteers (11-35) compared the administration of 400 mg doses once daily for 5<br />days. Mean Cmax and AUC values were slightly greater in the elderly. Elderly</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no findings from chronic toxicity investigations suggesting that any side<br />effects unknown to date could occur in humans. Furthermore, in vivo and in vitro<br />studies did not yield any indication of a potential to cause mutagenicity. Long-term<br />studies on carcinogenicity have not been conducted. Reproduction studies have been<br />performed in mice and rats at does up to 400 times the human dose and have revealed<br />no evidence of impaired fertility or harm to the foetus due to cefixime. In the rabbit,<br />at doses up to 4 times the human dose, there was no evidence of a teratogenic effect;<br />there was a high incidence of abortion and maternal death, which is an expected<br />consequence of the known hypersensitivity of rabbits to antibiotic-induced changes in<br />the population of the microflora of the intestine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium benzoate, silica colloidal anhydrous, xanthan gum, sucrose, tutti frutti flavor.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C. Discard unused content 14 days after reconstitution.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mixif suspension is available in bottles for preparing 60 ml or 30 ml flavored<br />suspensions. These bottles contain off white to yellowish powder. Comes with a<br />measuring spoon that can measure 2.5ml and 5ml.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of in accordance with local requirements.<br />For reconstitution of Mixif suspension:<br />&minus; Invert the bottle and shake content to loosen powder, add pre-boiled cooled water to the mark, and shake well, then add more water if necessary up to the mark and shake well until a homogeneous suspension is obtained<br />&minus; When first reconstituted, allow to stand for five minutes to ensure full dispersion<br />&minus; Shake the bottle well before use</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dar Al Dawa Development & Investment Co Ltd (Na'ur – Jordan).
Tel. (+962 6) 57 27 132
Fax. (+962 6) 57 27 776
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                26/04/2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>